
11 - 50 funcionários
🏥 Saúde
🧬 Biotecnologia
💊 Farmacêutico
💰 $300.000 Grant - BrainChild Bio em 2025-01
Healthcare • Biotechnology • Pharmaceuticals
A <BrainChild Bio> é uma empresa de biotecnologia em estágio clínico que desenvolve terapias com células CAR T direcionadas a tumores no sistema nervoso central (SNC). A empresa prioriza tumores cerebrais pediátricos, ao mesmo tempo que amplia sua plataforma para indicações adultas como glioblastoma e metástases cerebrais, visando avançar novas terapias celulares através de ensaios clínicos e traduzir sua ciência amplamente para melhorar os desfechos de crianças e adultos com cânceres no SNC.
🕒 Agosto 27
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $190.000 - $210.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
👻 Score fantasma 6%
🗣️🇺🇸🇬🇧 Inglês obrigatório
Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

11 - 50 funcionários
🏥 Saúde
🧬 Biotecnologia
💊 Farmacêutico
💰 $300.000 Grant - BrainChild Bio em 2025-01
Healthcare • Biotechnology • Pharmaceuticals
A <BrainChild Bio> é uma empresa de biotecnologia em estágio clínico que desenvolve terapias com células CAR T direcionadas a tumores no sistema nervoso central (SNC). A empresa prioriza tumores cerebrais pediátricos, ao mesmo tempo que amplia sua plataforma para indicações adultas como glioblastoma e metástases cerebrais, visando avançar novas terapias celulares através de ensaios clínicos e traduzir sua ciência amplamente para melhorar os desfechos de crianças e adultos com cânceres no SNC.
• Provide strategic quality leadership as the Quality representative on cross-functional teams, partnering with Process and Analytical Development, MSAT, Regulatory Affairs, Supply Chain, and external partners • Ensure scientifically sound, risk-based quality decisions throughout the lifecycle of cell therapy products, including development, technology transfer, characterization, validation, and continued process verification (CPV) • Review and approve CMC regulatory submissions, development and validation documentation, technical reports, comparability assessments, and regulatory responses • Support health authority inspections and interactions, and other due diligence activities • Drive continuous improvement of CMC Quality systems, processes, and organizational capabilities • Lead development and lifecycle management of product quality and risk-based control strategies aligned with QbD, QRM, ICH, and global regulatory expectations • Provide Quality oversight of CQAs, CPPs, CMAs, in-process controls, release strategies, and continued process verification • Assess quality impact of manufacturing, analytical, facility, supplier, and process changes • Oversee product, raw material, in-process, release, and stability specifications and analytical acceptance criteria • Provide strategic Quality oversight for internal Analytical Development laboratories and outsourced QC operations, including testing, analytical method lifecycle management, investigations, deviations, OOS/OOT events, CAPAs, and quality/compliance metrics • Oversee GMP sample lifecycle, retain programs, reference standards, and product traceability • Lead Quality oversight of sterility assurance programs, contamination control, aseptic processing, environmental monitoring, cleanroom qualification, microbiological controls, and Annex 1 compliance • Provide Quality oversight for CTLs, CDMOs, and other external partners through vendor qualification, audits, governance, quality agreements, technology transfer, manufacturing support, investigations, and change management
• Bachelor's or Master's degree in Life Sciences, Engineering, Pharmacy, Microbiology, Biochemistry, or a related scientific discipline; advanced degree preferred • 10+ years of progressive Quality experience in biotechnology, biologics, or advanced therapies, including at least 5 years supporting cell therapy or ATMP products • Demonstrated expertise supporting autologous and/or allogeneic cell therapy manufacturing, analytical testing, and lifecycle management • Demonstrated expertise in CMC Quality including QbD, QRM, control strategy development, QC oversight, analytical method lifecycle management, specifications, stability, sterility assurance, contamination control, process development, technology transfer and process validation • Extensive knowledge of GMP, GCP, ICH guidelines, FDA, EMA, and global regulatory requirements applicable to cell and gene therapies • Experience supporting regulatory inspections, Health Authority interactions, and maintaining inspection readiness • Excellent leadership, communication, and cross-functional collaboration skills, with demonstrated ability to influence internal and external stakeholders • Proven ability to manage competing priorities, lead complex technical quality initiatives, and make sound, risk-based decisions in a fast-paced, evolving environment • Experience implementing contamination control strategies aligned with EU GMP Annex 1 • Experience supporting regulatory submissions including INDs, BLAs, MAAs, and post-approval lifecycle changes
• Approximately 30–40% travel to CDMOs, Contract Testing Laboratories, suppliers, company locations, and regulatory or business meetings
Candidatar-se🕒 Agosto 27
Director overseeing enterprise application support, vendors, SLAs, and operational resilience for Sedgwick’s insurance services. Driving application stability, incident reduction, and continuous improvement across technology stakeholders.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Agosto 27
Director leading real-world data and HEOR strategy for Lilly’s life-changing medicines. Designing studies, guiding evidence generation, and connecting insights to clinical and regulatory decisions.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $165.000 - $290.400 / ano
💰 $6.500.000 Post-IPO Debt - Eli Lilly em 2024-02
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Agosto 27
Claims technical director guiding complex, litigated casualty liability claims for an insurance company. Coaching handlers on coverage, reserving, litigation, negotiation, and resolution strategy.
🇺🇸 Estados Unidos – Remoto (EUA)
💰 $500.000.000 Post-IPO Debt - The Hanover Insurance Group em 2025-08
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Agosto 27
Claims Technical Director guiding complex, litigated casualty liability claims for an insurance organization. Coaching handlers and optimizing coverage, reserving, litigation, and settlement outcomes.
🇺🇸 Estados Unidos – Remoto (EUA)
💰 $500.000.000 Post-IPO Debt - The Hanover Insurance Group em 2025-08
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Agosto 27
Director of Analytics driving analytics strategy for SoLo Funds, an AI-powered community bank. Leading data infrastructure, AI-powered insights, and analytics team development.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $150.000 - $180.000 / ano
💰 Venture Round - SoLo Funds em 2023-03
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🗣️🇺🇸🇬🇧 Inglês obrigatório